|
|||||||||||
|
FOR IMMEDIATE RELEASE Pico-Tesla reports promising results from pilot study of Magneceutical® Therapy for fibromyalgia CLEARWATER, Fla., April 13, 2011 —Pico-Tesla, The Magneceutical® Company, announced today that a randomized, double-blind, placebo-controlled pilot study of 13 patients who have fibromyalgia suggests promise for its Therapy designed to improve symptoms of Pain and Sleep in this patient population. The pilot study sought to determine whether the application of magnetic fields generated by Pico-Tesla’s patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia. “The results of this study suggest that Magneceutical® Therapy may improve the symptoms of Pain and Sleep in this patient population. This was a small study, but given the results, it certainly warrants a larger study, as this is a difficult disease and the current options for treatment are problematic,” said Miguel Trevino, M.D., Medical Director, Innovative Research of West Florida, Clearwater, Fla. Dr. Trevino is certified to practice medicine by the American Board of Internal Medicine. Innovative Research of West Florida is a leading Clinical Research Site. Fibromyalgia (pronounced fy-bro-my-AL-ja) is a common and complex chronic pain disorder that affects people physically, mentally and socially. Fibromyalgia, which has also been referred to as fibromyalgia syndrome, fibromyositis and fibrositis, is characterized by chronic widespread pain, multiple tender points, abnormal pain processing, sleep disturbances, fatigue and often psychological distress. For those with severe symptoms, fibromyalgia can be extremely debilitating and interfere with basic daily activities. (Source: National Fibromyalgia Association) Pico-Tesla’s Magneceutical® Therapy involves the use of an extremely low-level
electromagnetic field (EMF) applied by a specially designed device—the Resonator™,
invented by Dr. Jerry I. Jacobson, along with proprietary therapeutic protocols—
intended to improve a number of the signs and symptoms of fibromyalgia and other disorders and
diseases, including atrial fibrillation, Parkinson’s disease, Alzheimer’s disease and osteoarthritis. CAUTION: The Resonator™ device is an Investigational Device limited by federal (or United States) law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical™ Therapy generally available outside of Investigational Review Board (IRB)- approved clinical studies. |
4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722 |
